Profile data is unavailable for this security.
About the company
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
- Revenue in EUR (TTM)14.95m
- Net income in EUR-4.37m
- Incorporated2004
- Employees114.00
- LocationOptomed OyjYrttipellontie 1OULU 90230FinlandFIN
- Phone+358 207413380
- Fax+358 943153388
- Websitehttps://www.optomed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paxman AB (publ) | 18.08m | 716.82k | 65.28m | 91.00 | 91.56 | 6.19 | 28.16 | 3.61 | 0.4358 | 0.4358 | 11.03 | 6.45 | 1.23 | 2.70 | 7.67 | 2,308,978.00 | 4.89 | -5.08 | 6.65 | -7.76 | 69.68 | 69.38 | 3.96 | -5.07 | 1.67 | 2.71 | 0.1251 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Mentice AB | 21.86m | -2.24m | 69.09m | 128.00 | -- | 5.92 | 1,958.20 | 3.16 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| OssDsign AB | 10.13m | -10.19m | 74.37m | -- | -- | 3.85 | -- | 7.34 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | -- | -39.29 | -38.80 | -43.39 | -44.72 | 77.15 | 72.29 | -100.57 | -203.05 | 5.18 | -36.90 | 0.013 | -- | 96.82 | 53.26 | -31.30 | -- | -60.35 | -- |
| Integrum AB | 8.28m | 710.62k | 81.77m | 34.00 | 119.46 | 6.68 | 91.65 | 9.88 | 0.447 | 0.447 | 5.19 | 7.99 | 0.5918 | 0.5859 | 3.83 | -- | 5.08 | -6.65 | 5.65 | -7.95 | 86.80 | 81.52 | 8.58 | -11.19 | 3.04 | -4.28 | 0.0462 | -- | 33.29 | 37.39 | -117.50 | -- | 86.42 | -- |
| C Rad AB | 39.43m | 4.15m | 121.75m | 89.00 | 30.10 | 4.99 | 24.61 | 3.09 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Optomed Oyj | 14.95m | -4.37m | 123.11m | 114.00 | -- | 6.28 | -- | 8.24 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| ADDvise Group AB (publ) | 127.00m | 9.53m | 127.88m | 620.00 | 24.47 | 3.42 | 6.63 | 1.01 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Stille AB | 31.16m | 3.06m | 153.87m | 142.00 | 33.16 | 2.77 | 33.53 | 4.94 | 6.00 | 6.00 | 60.20 | 71.84 | 0.5364 | 1.77 | 7.18 | 3,416,557.00 | 5.27 | 7.03 | 6.35 | 8.19 | 46.76 | 43.93 | 9.82 | 9.85 | 0.9879 | 7.17 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
| Bactiguard Holding AB | 19.00m | -10.86m | 180.59m | 191.00 | -- | 6.90 | -- | 9.50 | -3.60 | -3.60 | 6.30 | 9.80 | 0.3035 | 4.28 | 6.00 | 1,017,544.00 | -17.35 | -7.56 | -19.82 | -8.81 | 29.87 | 47.91 | -57.15 | -26.28 | 1.64 | -11.90 | 0.4129 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| Sedana Medical AB (publ) | 14.19m | -1.96m | 183.79m | 83.00 | -- | 2.16 | 31,408.01 | 12.95 | -0.2299 | -0.2299 | 1.66 | 9.95 | 0.1564 | 1.24 | 8.10 | 2,087,443.00 | -2.17 | -5.77 | -2.28 | -6.08 | 70.50 | 64.06 | -13.85 | -36.13 | 7.38 | -- | 0.0043 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
Data as of May 23 2024. Currency figures normalised to Optomed Oyj's reporting currency: Euro EUR
33.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OP Asset Management Ltd.as of 29 Feb 2024 | 1.43m | 7.90% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Apr 2023 | 1.06m | 5.82% |
| Sp-Fund Management Co. Ltd.as of 30 Apr 2024 | 894.82k | 4.94% |
| Aktia Bank Plc (Investment Management)as of 30 Apr 2024 | 687.41k | 3.79% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 29 Feb 2024 | 561.92k | 3.10% |
| eQ Varainhoito Oyas of 29 Feb 2024 | 386.99k | 2.13% |
| Nordea Investment Management ABas of 29 Feb 2024 | 361.13k | 1.99% |
| Keskin�inen Vakuutusyhti� Kalevaas of 29 Feb 2024 | 322.04k | 1.78% |
| Carnegie Investment Bank AB (Investment Management Denmark)as of 31 Dec 2021 | 249.08k | 1.37% |
| Danske Bank A/S (Investment Management Finland)as of 27 Mar 2024 | 165.45k | 0.91% |
More ▼
Data from 31 Dec 2021 - 30 Apr 2024Source: FactSet Research Systems Inc.
